Anidulafungin-induced Hepatotoxicity and Dose Reduction: A Case Report
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2016, Vol 6, Issue 3
Abstract
Anidulafungin, the newest echinocandin antifungal recently approved by the U.S. FDA, is unique among echinocandins as it undergoes biotransformation rather than being metabolized. In general, patients who received anidulafungin demonstrated low rates of adverse events. Hepatotoxicity is uncommon with anidulafungin and to date; there is no information on hepatic dose adjustments and it is also unknown if the adverse events are dose-related. We describe a patient who developed raised alkaline phosphatase (ALP) upon exposure to a high maintenance dose of anidulafungin at 200 mg every morning. Our patient has a persistent active mitral valve Candida endocarditis, complicated with recurrent candidemia. Patient received multiple courses of anti-fungal agents but breakthrough while on oral anti-fungal suppressive therapy. Prior to the initiation of high dose anidulafungin therapy, patient’s liver function tests were all normal. One month after the initiation of high dose anidulafungin, repeat blood tests revealed a raised ALP level to 3 times the upper normal limit. As prolonged anti-fungal therapy is necessary, the maintenance dose of anidulafungin was reduced to 100 mg every morning, even though patient remained well. Three months after dose reduction, patient’s serum ALP levels showed a steady decrease to 1 time the upper normal limit. In this patient that we have reported – taking into consideration of the temporal relationship of events, coupled with the probability scoring using the Naranjo Algorithm, it is probable that anidulafungin may exhibit dose-related hepatotoxicity resulting in elevated serum ALP levels and such adverse events may be mitigated with dose reduction.
Authors and Affiliations
L. W. Loo, Jocelyn Teo, Tan Thuan Tong, Winnie Lee, Andrea L. Kwa
Keywords
Related Articles
- EP ID EP327738
- DOI 10.9734/IJMPCR/2016/22272
- Views 112
- Downloads 0
Autoimmune Progesterone Dermatitis with Post-Inflammatory Hyperpigmentation
Autoimmune Progesterone dermatitis is a rare disorder characterized by recurrent cyclical cutaneous eruptions during the menstrual period, and is due to hypersensitivity to progesterone. It is a dermatosis with myriad mo...
Unusual Cause of Rhabdomyolysis Causing Acute Renal Failure: Achillea millefolium and
Introduction: Rhabdomyolysis is a frequent disorder resulting from many different causes which may be apparent from the history, e.g. trauma, heavy exercise, intoxications. It contains both clinical and biochemical compo...
Bisphosphonate-Associated Bilateral Atraumatic Ulna Fractures
Aims: From 2003, low-impact fractures have been reported in association with bisphosphonate (BP) therapy. Most have involved the proximal femur, but over 100 cases involving other anatomic locations have been published....
Internal Resorption: A Report of Two Cases
Internal resorption is generally noted in teeth with previous history of trauma. Often the tooth is asymptomatic. The diagnosis of this condition at an early stage improves the prognosis of such teeth. Therefore it is im...
How to Manage an Anticoagulated Patient in Case of Drug-Drug Interaction?
Aims: The aim of this publication is to present the case of management of a patient on anticoagulation therapy with rivaroxoban in the context of a drug-drug interaction. Presentation of Case: We report the case of a 73-...